BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 27732939)

  • 1. Dysregulation of long non-coding RNA in breast cancer: an overview of mechanism and clinical implication.
    Wang J; Ye C; Xiong H; Shen Y; Lu Y; Zhou J; Wang L
    Oncotarget; 2017 Jan; 8(3):5508-5522. PubMed ID: 27732939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A brief review on long noncoding RNAs: a new paradigm in breast cancer pathogenesis, diagnosis and therapy.
    Malih S; Saidijam M; Malih N
    Tumour Biol; 2016 Feb; 37(2):1479-85. PubMed ID: 26662315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding and circular RNAs in lung cancer: advances and perspectives.
    Xie W; Yuan S; Sun Z; Li Y
    Epigenomics; 2016 Sep; 8(9):1275-87. PubMed ID: 27585562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNAs in regulation of human breast cancer.
    Wang G; Liu C; Deng S; Zhao Q; Li T; Qiao S; Shen L; Zhang Y; Lü J; Meng L; Liang C; Yu Z
    Brief Funct Genomics; 2016 May; 15(3):222-6. PubMed ID: 26582840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNAs as prognostic markers in human breast cancer.
    Liu H; Li J; Koirala P; Ding X; Chen B; Wang Y; Wang Z; Wang C; Zhang X; Mo YY
    Oncotarget; 2016 Apr; 7(15):20584-96. PubMed ID: 26942882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of long non-coding RNAs in cancer patients: From biomarkers to therapeutic targets.
    Chandra Gupta S; Nandan Tripathi Y
    Int J Cancer; 2017 May; 140(9):1955-1967. PubMed ID: 27925173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNA and long non-coding RNA: molecular function and clinical value in breast and ovarian cancers.
    Panoutsopoulou K; Avgeris M; Scorilas A
    Expert Rev Mol Diagn; 2018 Nov; 18(11):963-979. PubMed ID: 30338716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Status of Long Non-Coding RNAs in Human Breast Cancer.
    Cerk S; Schwarzenbacher D; Adiprasito JB; Stotz M; Hutterer GC; Gerger A; Ling H; Calin GA; Pichler M
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27608009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer.
    Mouraviev V; Lee B; Patel V; Albala D; Johansen TE; Partin A; Ross A; Perera RJ
    Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):14-20. PubMed ID: 26503110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNAs (lncRNAs) in triple negative breast cancer.
    Wang Q; Gao S; Li H; Lv M; Lu C
    J Cell Physiol; 2017 Dec; 232(12):3226-3233. PubMed ID: 28138992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of potential prognostic long non-coding RNA biomarkers for predicting the risk of tumor recurrence of breast cancer patients.
    Zhou M; Zhong L; Xu W; Sun Y; Zhang Z; Zhao H; Yang L; Sun J
    Sci Rep; 2016 Aug; 6():31038. PubMed ID: 27503456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consensus Analysis of Whole Transcriptome Profiles from Two Breast Cancer Patient Cohorts Reveals Long Non-Coding RNAs Associated with Intrinsic Subtype and the Tumour Microenvironment.
    Bradford JR; Cox A; Bernard P; Camp NJ
    PLoS One; 2016; 11(9):e0163238. PubMed ID: 27685983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hypoxia-responsive long non-coding RNAs may impact on the tumor biology and subsequent management of breast cancer.
    Kapinova A; Kubatka P; Zubor P; Golubnitschaja O; Dankova Z; Uramova S; Pilchova I; Caprnda M; Opatrilova R; Richnavsky J; Kruzliak P; Danko J
    Biomed Pharmacother; 2018 Mar; 99():51-58. PubMed ID: 29324312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA in prostate, bladder, and kidney cancer.
    Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
    Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel long non-coding RNA FGF14-AS2 is correlated with progression and prognosis in breast cancer.
    Yang F; Liu YH; Dong SY; Ma RM; Bhandari A; Zhang XH; Wang OC
    Biochem Biophys Res Commun; 2016 Feb; 470(3):479-483. PubMed ID: 26820525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNAs as monitoring tools and therapeutic targets in breast cancer.
    Pecero ML; Salvador-Bofill J; Molina-Pinelo S
    Cell Oncol (Dordr); 2019 Feb; 42(1):1-12. PubMed ID: 30361825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long Non-Coding RNAs: the New Horizon of Gene Regulation in Ovarian Cancer.
    Worku T; Bhattarai D; Ayers D; Wang K; Wang C; Rehman ZU; Talpur HS; Yang L
    Cell Physiol Biochem; 2017; 44(3):948-966. PubMed ID: 29179183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targetable long non-coding RNAs in cancer treatments.
    Chen L; Dzakah EE; Shan G
    Cancer Lett; 2018 Apr; 418():119-124. PubMed ID: 29341880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNAs: new insights into non-small cell lung cancer biology, diagnosis and therapy.
    Ricciuti B; Mencaroni C; Paglialunga L; Paciullo F; Crinò L; Chiari R; Metro G
    Med Oncol; 2016 Feb; 33(2):18. PubMed ID: 26786153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNAs and neoplasia.
    Isin M; Dalay N
    Clin Chim Acta; 2015 Apr; 444():280-8. PubMed ID: 25748036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.